Upgrade to SI Premium - Free Trial

Novocure (NVCR)

16.72 +0.07 (0.42%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/23/26)

Latest Headlines

Form 8-K NovoCure Ltd For: Jun 03 June 5, 2026 4:30 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 04 Filed by: Leonard Frank X June 5, 2026 4:28 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: LEUNG GABRIEL June 5, 2026 4:28 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: Stafford Kristin June 5, 2026 4:28 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: Ocean Allyson J June 5, 2026 4:27 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: Scannell Timothy J June 5, 2026 4:27 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: HILLEMAN JERYL L June 5, 2026 4:27 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: Hung David June 5, 2026 4:26 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: Madden Martin J. June 5, 2026 4:26 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: VERNON W ANTHONY June 5, 2026 4:26 PM - SEC Filing Form 144 NovoCure Ltd Filed by: Leonard Frank X June 4, 2026 5:41 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 02 Filed by: LEUNG GABRIEL June 3, 2026 4:54 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 02 Filed by: Stafford Kristin June 3, 2026 4:54 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 02 Filed by: Ocean Allyson J June 3, 2026 4:54 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 02 Filed by: Scannell Timothy J June 3, 2026 4:53 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 02 Filed by: HILLEMAN JERYL L June 3, 2026 4:53 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 02 Filed by: VERNON W ANTHONY June 3, 2026 4:53 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 02 Filed by: Hung David June 3, 2026 4:53 PM - SEC Filing Form DEFA14A NovoCure Ltd May 21, 2026 4:00 PM - SEC Filing Form SCHEDULE 13G/A NovoCure Ltd Filed by: Soleus Capital Master Fund, L.P. May 8, 2026 5:02 PM - SEC Filing NovoCure Ltd. (NVCR) PT Raised to $17 at Wells Fargo May 4, 2026 6:51 AM - StreetInsider NovoCure Ltd. (NVCR) PT Raised to $20 at Evercore ISI April 30, 2026 12:22 PM - StreetInsider Novocure (NVCR) Misses Q1 EPS by 13c, provides guidance April 30, 2026 7:13 AM - StreetInsider Form 8-K NovoCure Ltd For: Apr 30 April 30, 2026 7:02 AM - SEC Filing Form 10-Q NovoCure Ltd For: Mar 31 April 30, 2026 7:01 AM - SEC Filing Novocure Reports First Quarter 2026 Financial Results April 30, 2026 7:00 AM - BizWire Form 4 NovoCure Ltd For: Apr 28 Filed by: VERNON W ANTHONY April 28, 2026 4:28 PM - SEC Filing Form SCHEDULE 13G NovoCure Ltd Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC April 28, 2026 3:30 PM - SEC Filing Form 8-K/A NovoCure Ltd For: Nov 24 April 24, 2026 4:10 PM - SEC Filing Form DEFA14A NovoCure Ltd April 20, 2026 4:06 PM - SEC Filing Form DEF 14A NovoCure Ltd For: Jun 03 April 20, 2026 4:06 PM - SEC Filing Form 8-K NovoCure Ltd For: Apr 08 April 9, 2026 5:04 PM - SEC Filing NovoCure Ltd. (NVCR) PT Lowered to $16 at Evercore ISI April 6, 2026 8:28 AM - StreetInsider Novocure to Report First Quarter 2026 Financial Results April 1, 2026 7:00 AM - BizWire Form SCHEDULE 13G/A NovoCure Ltd Filed by: VANGUARD GROUP INC March 26, 2026 11:52 AM - SEC Filing Form 8-K NovoCure Ltd For: Mar 26 March 26, 2026 7:02 AM - SEC Filing Novocure reports positive phase 2 trial results for pancreatic cancer March 26, 2026 7:00 AM - StreetInsider Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer March 26, 2026 7:00 AM - BizWire Full Article List